Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Medicine » Cancer » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Doxycycline: Medical Uses and Effects
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
01.Experimental Leukemia: History, Biology and Genetics
02.Cancer Metastasis Research: Pathological Insight
03.Eye Cancer Research Progress
04.Mesothelioma from Bench Side to Clinic
05.Photodynamic Therapy: New Research
06.Cancer and Stem Cells
07.Oncology Social Work Practice in the Care of Breast and Ovarian Cancer Survivors
08.Progress in Oral Cancer Research
09.New Research on Cutaneous Lymphomas
10.Aromatase Inhibitors: Types, Mode of Action and Indications
Notifications more
NotificationsNotify me of updates to Anticancer Drugs: Design, Delivery and Pharmacology
Tell A Friend
Tell someone you know about this product.
Anticancer Drugs: Design, Delivery and Pharmacology
Retail Price: $195.00
10% Online Discount
You Pay:

Editors: Peter Spencer and Walter Holt
Book Description:
This book describes several ways to improve drug localization and to increase anti-tumor efficacy, such as through drug modifications and through the development of anti-tumor drug delivery systems. Anticancer drugs have little or no specificity, resulting in low tumor concentrations, systemic toxicity and severe side effects. The pharmacological inhibitors of Hsp90, a major cytosolic chaperone, are examined in this book since they are often used in anticancer therapy. Furthermore, polyphenols, an anti-cancer agent which constitutes the most abundant group of antioxidants of normal human food, is discussed as well. Polyphenols protect against oxidative stress and their associated pathologies include inflammation, cancer and coronary heart diseases. Thus, they play an important role as an anticancer agent. Finally, metal-based antitumor drugs, which play an essential role in clinics today are reviewed. In particular, ruthenium compounds as promising alternatives to platinum-based anticancer drugs.

Table of Contents:

Research and Review Studies

Micro- and Nano-Particulate Drug Delivery Systems for Cancer Treatment
(Jose L. Arias - Dept. of Pharmacy and Pharmaceutical Technology, Univ. of Granada, Granada, Spain)pp.1-86

Geldanamycin Derivatives as Promising Anticancer Drugs: Therapy via Hsp90 Inhibition
(Alexander E. Kabakov - Dept. of Radiation Biochemistry, Medical Radiology Research Center, Obninsk, Russia)pp.87-114

Synergistic Antitumor Activity of Metronomic Dosing Chemotherapy in Combination with Liposomal Anticancer Drug
(Tatsuhiro Ishida, Hiroshi Kiwada - Dept. of Pharmacokinetics and Biopharmaceutics, Univ. of Tokushima, Sho-machi, Tokushima, Japan)pp.115-144

Organotin Polyethers as Anticancer Drugs
(Charles E. Carraher, Jr., Michael R. Roner, Girish Barot - Florida Atlantic Univ., Dept. of Chemistry and Biochemistry, Boca Raton, FL and others)pp.145-170

Studies on Anticancer Agents: Phenolic Compounds and their Pharmacological Activity
(Maria Dolors Pujol, Isabel Sanchez - Laboratori de Quimica Farmaceutica, Univ. de Barcelona, Barcelona, Spain) pp.171-194

Design of Novel Anticancer Drugs Utilizing Busulfan for Optimizing Pharmacological Properties and Pattern Recognition Techniques for Elucidation of Clinical Efficacy
(Ronald Bartzatt - Univ. of Nebraska, Chemistry Department, Omaha, NE, USA)pp.195-210

Analysis of Associations Among Novel Property Descriptors and their Capacity in Determining Clinical Efficacy by Utilizing Pattern Recognition Technigues
(Ronald Bartzatt - Univ. of Nebraska, Chemistry Department, Omaha, NE, USA)pp.211-226

Insights into the Mode of Action of Investigational Ruthenium(III) Cytotoxins from Electrochemical and Biological Studies
Erwin Reisner - Univ. of Oxford, Inorganic Chemistry Laboratory, Oxford, UK)pp.227-238

Short Communication

Marina Crystal Minerals(MCM) Induce Apoptosis of Human Metastatic Breast Cancer MDA-MB-231 Cells In Vitro
(Mamdooh Ghoneum, Takeshi Ogura, Sastry Gollapudi- Dept. of Otolaryngology, Drew Univ. of Medicine and Science, Los Angeles, CA, USA and others)pp.239-248

Index pp.249-271

      Cancer Etiology, Diagnosis and Treatments
   Binding: Hardcover
   Pub. Date: 2011 - 2nd quarter
   Pages: 7 x 10, pp.271
   ISBN: 978-1-60741-004-1
   Status: AV
Status Code Description
AN Announcing
FM Formatting
PP Page Proofs
FP Final Production
EP Editorial Production
PR At Prepress
AP At Press
AV Available
Customers who bought this product also purchased
Biopharmaceutics and Drug Hypersensitivity
Biopharmaceutics and Drug Hypersensitivity

Triglycerides: Chemical Structure, Biosynthesis and Role in Disease
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2022

Anticancer Drugs: Design, Delivery and Pharmacology